COMP <GO>
UPXI vs BRK-B // FORWARD P/E MULTIPLE
Upexi Inc. (NASDAQ) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: UPXI 0
— BRK-B 8
■ METRIC PARITY
LAST: $0.76 (-7.39%) • MKT CAP: $72.3M
forward-pe
—
LAST: $542.49 (+0.10%) • MKT CAP: $1.20T
forward-pe
24.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UPXI VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UPXI | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -20.30% | 11.47% | -31.77 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 9.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.19% | 2.09% | -14.28 | BRK-B | /fcf-yield <GO> |
| Operating Margin | -60.00% | 27.80% | -87.80 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 22.30% | -82.30 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | 3.93% | -68.93 | BRK-B | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.85 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | BRK-B | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 3.55% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.8 | 67.7 | -36.90 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.61 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 24.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $72.3M | $1.20T | -$1.20T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UPXI REV | BRK-B REV | UPXI GROSS % | BRK-B GROSS % | UPXI FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $985.0K | $371.44B | — | — | -$8.8M | $25.04B |
| FY 2024 | $26.0M | $371.43B | — | — | -$1.0M | $11.62B |
| FY 2023 | $36.4M | $364.48B | — | — | $202.7K | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UPXI // BETA —
BRK-B // BETA 0.61